Maryland: Prior authorization requirements for Cinryze®, Spinraza® and Zolgensma®

Effective May 1, 2021, you will need to submit prior authorization for Cinryze, Spinraza, and Zolgensma for UnitedHealthcare Community Plan members in Maryland. These requirements will apply whether members are new to therapy or have already been receiving these medications.

You can submit prior authorization requests in the following ways:

  • Online: Use the Prior Authorization and Notification tool on Link. Go to UHCprovider.com/paan.
  • Call: Use the Provider Services phone number on the member’s health care identification card.

If you administer these medications without first completing the prior authorization process, we may deny the claim and you won’t be able to balance bill members.